News
News
OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease...
Read moreDetails
OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to its Scientific Advisory Board
OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) to...
Read moreDetails
Mawson Infrastructure Group Inc Relocating 5,376 ASIC Miners to Pennsylvania Sites
Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announces today that it has closed its...
Read moreDetailsMawson Infrastructure Group Inc Expands Midland PA Facility by 100% to 100MW
Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announces today that it has installed 2...
Read moreDetails
NanoViricides Has Filed its Quarterly Report – Company has Begun Production of Coronavirus Drug for Clinical Trials
Wednesday, February 15, 2023 -- NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that it has filed its Quarterly Report...
Read moreDetailsOKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023.
OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease...
Read moreDetails
Laser Photonics Receives CDHR/FDA Renewal Approval for CleanTech Products
Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial CleanTech laser systems for laser cleaning and other...
Read moreDetails
Amesite Announces GPT-3 Powered Functionality to Its AI Toolkit for Customers and Users
Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention...
Read moreDetailsLaser Photonics Announces Plans for Next Generation Utility Grade CleanTech Laser Systems
Laser Photonics Corporation (NASDAQ: LASE) (“LPC”), a leading global developer of industrial CleanTech laser systems for laser cleaning and other...
Read moreDetails
SUNSHINE BIOPHARMA SIGNS RESEARCH AGREEMENT WITH THE JEWISH GENERAL HOSPITAL TO ADVANCE THE DEVELOPMENT OF Adva-27a ANTICANCER COMPOUND
Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including...
Read moreDetails